wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q43990034-E0126C3B-4258-4456-8596-4E85B00AAE41
Q43990034-E0126C3B-4258-4456-8596-4E85B00AAE41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43990034-E0126C3B-4258-4456-8596-4E85B00AAE41
More on normal prothrombin times in the presence of therapeutic levels of rivaroxaban--early experience from King's College Hospital.
P2860
Q43990034-E0126C3B-4258-4456-8596-4E85B00AAE41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43990034-E0126C3B-4258-4456-8596-4E85B00AAE41
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c7d322a2eb63a043290304f26991105267c95c9
P2860
Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.